Nutrition During Childhood Cancer Treatment: Current Understanding and a Path for Future Research
Course Description:
In this course, Elena J. Ladas, PhD, RD will describe how under- and overnutrition are important contributors to a pediatric oncology patient’s morbidity, quality of life, and mortality; discuss the consequences of cancer and review the short- and long-term nutritional implications; and explain how to recognize the evaluation of nutritional status as an essential component of oncology care. Originally presented as a live webinar on October 20, 2022.Course Objectives:
- Run Time: 41
Course Instructor Bio(s)

Elena J. Ladas, PhD, RD
Dr Elena J. Ladas is the Sid and Helaine Lerner Associate Professor for Global Integrative Medicine in the Division of Pediatric Hematology/Oncology/Stem Cell Transplant at Columbia University Irving Medical Center (CUIMC). Dr Ladas received a Master’s degree in nutritional biochemistry from the Institute of Human Nutrition at CUIMC and holds a PhD in nutrition epidemiology from Columbia University. She is also a registered dietitian.
Dr Ladas is a clinical investigator with expertise in the clinical integration and scientific evaluation of nutrition and complementary/alternative medicine in pediatric oncology. Dr Ladas is the Director of the Integrative Therapies Program and Co-Director of the Center for Comprehensive Wellness (CCW), where she is responsible for the clinical oversight and research portfolio of nutrition and integrative therapies. Dr Ladas is the principal investigator on several multi-institutional studies that evaluate the role of nutrition and integrative therapies, as components of supportive care, during and after treatment for childhood cancer. Specifically, she is evaluating the influence of dietary intake on the development of nutrition-related morbidities (such as obesity) in children with acute lymphoblastic leukemia through a collaboration with the Dana Farber ALL Consortium. Dr Ladas serves as the Chair of the nutrition committee of Children’s Oncology Group (COG) and is the principal investigator of an R01-funded study that is investigating the role of probiotic therapy on the development of gastrointestinal acute graft-versus-host disease among children and adolescents undergoing hematopoietic cell transplantation. Dr Ladas also leads a multi-institution study evaluating the clinical effects of perturbations on the microbiome among children with acute lymphoblastic leukemia.

ANHI partners with CMEfy, a platform that directs learners to reflect at the point of inspiration, or the Internet Point of Care Learning. CMEfy does not endorse, support or amplify ANHI content or learning experiences.
Dietitians, Nurses, Nurse Practitioners, Physicians, Physician Associates, Pharmacists, and other select healthcare professionals may earn up to 1.0 (0.5 CME/CE credit per reflection) per program at the point of care via the self-directed accredited activity experience, not for viewing, attending, or consuming ANHI content.

Our Learning Approaches
Traditional and Reflective Learning

attended a live program?
FREQUENTLY ASKED QUESTIONS
continuing medical education courses